 Robert Quaife
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 12 | 2021 | 132 | 1.120 |
Why?
| | Echocardiography, Three-Dimensional | 13 | 2019 | 71 | 1.100 |
Why?
| | Heart Septal Defects, Atrial | 5 | 2015 | 58 | 1.040 |
Why?
| | Cardiac Catheterization | 10 | 2021 | 558 | 0.810 |
Why?
| | Mitral Valve | 6 | 2019 | 95 | 0.720 |
Why?
| | Adrenergic beta-Antagonists | 6 | 2017 | 252 | 0.650 |
Why?
| | Cardiomyopathy, Dilated | 7 | 2024 | 356 | 0.640 |
Why?
| | Ultrasonography, Interventional | 5 | 2020 | 165 | 0.610 |
Why?
| | Radiography, Interventional | 7 | 2020 | 128 | 0.570 |
Why?
| | Mitral Valve Insufficiency | 2 | 2019 | 68 | 0.530 |
Why?
| | Propanolamines | 5 | 2003 | 40 | 0.470 |
Why?
| | Carbazoles | 5 | 2003 | 53 | 0.460 |
Why?
| | Echocardiography | 5 | 2020 | 647 | 0.460 |
Why?
| | Tropheryma | 1 | 2015 | 6 | 0.460 |
Why?
| | Whipple Disease | 1 | 2015 | 7 | 0.460 |
Why?
| | Endocarditis, Bacterial | 1 | 2015 | 46 | 0.440 |
Why?
| | Ventricular Function, Right | 3 | 2006 | 297 | 0.430 |
Why?
| | Eisenmenger Complex | 2 | 2013 | 13 | 0.400 |
Why?
| | Coronary Angiography | 3 | 2014 | 328 | 0.380 |
Why?
| | Microbubbles | 1 | 2013 | 53 | 0.370 |
Why?
| | Purines | 2 | 2022 | 187 | 0.370 |
Why?
| | Sodium Chloride | 1 | 2013 | 138 | 0.360 |
Why?
| | Myocardium | 8 | 2017 | 934 | 0.350 |
Why?
| | Heart Defects, Congenital | 5 | 2020 | 910 | 0.350 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2021 | 198 | 0.350 |
Why?
| | Ventricular Function, Left | 5 | 2017 | 542 | 0.310 |
Why?
| | Multimodal Imaging | 4 | 2020 | 129 | 0.310 |
Why?
| | Pyrazoles | 2 | 2022 | 517 | 0.300 |
Why?
| | Ventricular Function | 2 | 2006 | 53 | 0.300 |
Why?
| | Transposition of Great Vessels | 2 | 2013 | 41 | 0.280 |
Why?
| | Seizures | 1 | 2012 | 483 | 0.260 |
Why?
| | Stroke Volume | 7 | 2017 | 654 | 0.250 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2013 | 248 | 0.240 |
Why?
| | Hypertension, Pulmonary | 5 | 2006 | 1957 | 0.240 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2022 | 261 | 0.230 |
Why?
| | Ventricular Remodeling | 2 | 2017 | 278 | 0.220 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2024 | 214 | 0.210 |
Why?
| | Fluoroscopy | 6 | 2021 | 180 | 0.200 |
Why?
| | Ventricular Dysfunction | 1 | 2003 | 16 | 0.190 |
Why?
| | Heart Injuries | 1 | 2023 | 42 | 0.190 |
Why?
| | Theophylline | 1 | 2022 | 41 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 4 | 2014 | 2769 | 0.180 |
Why?
| | Myocarditis | 1 | 2023 | 102 | 0.180 |
Why?
| | Predictive Value of Tests | 7 | 2019 | 2121 | 0.170 |
Why?
| | Neoplasm Seeding | 1 | 2001 | 7 | 0.170 |
Why?
| | Heart Diseases | 2 | 2019 | 341 | 0.170 |
Why?
| | Humans | 51 | 2024 | 145475 | 0.170 |
Why?
| | Heart Valve Prosthesis | 2 | 2021 | 129 | 0.170 |
Why?
| | Tomography, Emission-Computed | 1 | 2001 | 71 | 0.170 |
Why?
| | Heart Valve Diseases | 2 | 2015 | 151 | 0.170 |
Why?
| | Catheterization | 3 | 2010 | 183 | 0.160 |
Why?
| | Peritoneal Neoplasms | 1 | 2001 | 104 | 0.160 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2001 | 161 | 0.150 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2014 | 143 | 0.150 |
Why?
| | Heart Failure | 4 | 2017 | 2326 | 0.150 |
Why?
| | Middle Aged | 21 | 2024 | 36215 | 0.150 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2019 | 37 | 0.140 |
Why?
| | Heart Ventricles | 3 | 2017 | 756 | 0.140 |
Why?
| | Myocardial Ischemia | 2 | 2000 | 285 | 0.140 |
Why?
| | Male | 23 | 2024 | 72843 | 0.130 |
Why?
| | Treatment Outcome | 11 | 2021 | 11772 | 0.130 |
Why?
| | Esophageal Neoplasms | 1 | 2001 | 348 | 0.120 |
Why?
| | Ethanol | 2 | 2014 | 631 | 0.120 |
Why?
| | Heart Septum | 2 | 2014 | 27 | 0.120 |
Why?
| | Magnets | 1 | 2016 | 21 | 0.120 |
Why?
| | Contrast Media | 2 | 2013 | 497 | 0.120 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 3 | 2017 | 104 | 0.120 |
Why?
| | Ferric Compounds | 1 | 2016 | 54 | 0.120 |
Why?
| | Metal Nanoparticles | 1 | 2016 | 80 | 0.110 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2015 | 288 | 0.110 |
Why?
| | Aged | 13 | 2024 | 26153 | 0.110 |
Why?
| | Radionuclide Imaging | 3 | 2012 | 115 | 0.110 |
Why?
| | Fatal Outcome | 1 | 2015 | 305 | 0.110 |
Why?
| | Hemodynamics | 5 | 2009 | 1118 | 0.110 |
Why?
| | Septal Occluder Device | 2 | 2015 | 37 | 0.100 |
Why?
| | Therapy, Computer-Assisted | 1 | 2014 | 63 | 0.100 |
Why?
| | Cardiac Resynchronization Therapy Devices | 1 | 2013 | 18 | 0.100 |
Why?
| | Balloon Valvuloplasty | 1 | 2013 | 5 | 0.100 |
Why?
| | Adenocarcinoma | 1 | 2001 | 925 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 1 | 2016 | 355 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 114 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2015 | 242 | 0.100 |
Why?
| | Surgery, Computer-Assisted | 2 | 2013 | 85 | 0.090 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2014 | 189 | 0.090 |
Why?
| | Vasodilator Agents | 2 | 2012 | 330 | 0.090 |
Why?
| | Adenosine A2 Receptor Antagonists | 1 | 2012 | 14 | 0.090 |
Why?
| | Catheter Ablation | 1 | 2016 | 355 | 0.090 |
Why?
| | Myocytes, Cardiac | 1 | 2017 | 546 | 0.090 |
Why?
| | Heart Transplantation | 2 | 2015 | 680 | 0.090 |
Why?
| | Checklist | 1 | 2013 | 110 | 0.090 |
Why?
| | Autonomic Nervous System | 2 | 2002 | 82 | 0.090 |
Why?
| | Female | 19 | 2024 | 78845 | 0.080 |
Why?
| | Aortic Valve Stenosis | 1 | 2014 | 256 | 0.080 |
Why?
| | Aortic Valve | 1 | 2014 | 364 | 0.080 |
Why?
| | Myosin Heavy Chains | 3 | 2002 | 183 | 0.080 |
Why?
| | Adult | 15 | 2024 | 40777 | 0.080 |
Why?
| | MicroRNAs | 1 | 2017 | 686 | 0.080 |
Why?
| | Radiology | 1 | 2013 | 174 | 0.080 |
Why?
| | Peptidyl-Dipeptidase A | 3 | 2006 | 56 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2014 | 583 | 0.080 |
Why?
| | Myocardial Reperfusion Injury | 1 | 1991 | 139 | 0.080 |
Why?
| | Academic Medical Centers | 1 | 2013 | 554 | 0.080 |
Why?
| | Blood Pressure | 3 | 2002 | 1779 | 0.080 |
Why?
| | Myocardial Contraction | 1 | 1991 | 293 | 0.070 |
Why?
| | Prospective Studies | 5 | 2014 | 8057 | 0.070 |
Why?
| | Prosthesis Implantation | 2 | 2013 | 154 | 0.070 |
Why?
| | Cardiac Output, Low | 1 | 2009 | 53 | 0.070 |
Why?
| | Exercise Test | 1 | 2012 | 630 | 0.070 |
Why?
| | Radiopharmaceuticals | 2 | 2001 | 205 | 0.070 |
Why?
| | Image Enhancement | 1 | 2009 | 200 | 0.070 |
Why?
| | Prosthesis Design | 1 | 2010 | 354 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2009 | 718 | 0.070 |
Why?
| | Linear Models | 1 | 2010 | 845 | 0.070 |
Why?
| | Nuclear Medicine | 1 | 2007 | 9 | 0.070 |
Why?
| | Echocardiography, Doppler | 1 | 2008 | 115 | 0.070 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2008 | 38 | 0.070 |
Why?
| | Gene Expression | 3 | 2002 | 1476 | 0.060 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2007 | 394 | 0.060 |
Why?
| | Receptors, Adrenergic, beta | 3 | 2002 | 58 | 0.060 |
Why?
| | Cardiomegaly | 2 | 2006 | 174 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2597 | 0.060 |
Why?
| | Splenic Neoplasms | 1 | 2006 | 5 | 0.060 |
Why?
| | Lymphangioma | 1 | 2006 | 9 | 0.060 |
Why?
| | Patient Selection | 1 | 2010 | 738 | 0.060 |
Why?
| | Comprehension | 1 | 2008 | 186 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 122 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2024 | 5423 | 0.060 |
Why?
| | Diagnostic Imaging | 1 | 2008 | 337 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 4 | 2014 | 3904 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2006 | 283 | 0.060 |
Why?
| | Aneurysm, False | 1 | 2005 | 46 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1845 | 0.050 |
Why?
| | Aortic Aneurysm | 1 | 2005 | 70 | 0.050 |
Why?
| | Cardiology | 1 | 2007 | 362 | 0.050 |
Why?
| | Exercise | 2 | 2009 | 2198 | 0.050 |
Why?
| | Sensitivity and Specificity | 3 | 2019 | 1997 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2019 | 8333 | 0.050 |
Why?
| | Embolization, Therapeutic | 1 | 2005 | 242 | 0.050 |
Why?
| | Young Adult | 3 | 2023 | 14219 | 0.050 |
Why?
| | Aminophylline | 1 | 2022 | 12 | 0.050 |
Why?
| | Aorta | 1 | 2005 | 440 | 0.050 |
Why?
| | Yttrium | 1 | 2002 | 5 | 0.050 |
Why?
| | Death, Sudden, Cardiac | 1 | 2024 | 232 | 0.050 |
Why?
| | Double-Blind Method | 2 | 1998 | 2062 | 0.040 |
Why?
| | Ascitic Fluid | 1 | 2001 | 15 | 0.040 |
Why?
| | Adolescent | 4 | 2023 | 22530 | 0.040 |
Why?
| | Solvents | 2 | 2014 | 112 | 0.040 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2930 | 0.040 |
Why?
| | Fees and Charges | 1 | 2000 | 12 | 0.040 |
Why?
| | Heart Rate | 3 | 2002 | 855 | 0.040 |
Why?
| | Immunoconjugates | 1 | 2002 | 138 | 0.040 |
Why?
| | Heart | 2 | 2001 | 626 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2024 | 17291 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2000 | 221 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2007 | 1581 | 0.040 |
Why?
| | Computer Systems | 2 | 2009 | 55 | 0.040 |
Why?
| | Melanoma | 1 | 2006 | 759 | 0.040 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 31 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2019 | 45 | 0.040 |
Why?
| | Reoperation | 1 | 2021 | 633 | 0.030 |
Why?
| | Technetium Tc 99m Pentetate | 1 | 1997 | 7 | 0.030 |
Why?
| | Biopsy | 2 | 2017 | 1082 | 0.030 |
Why?
| | Calcium-Transporting ATPases | 3 | 2002 | 33 | 0.030 |
Why?
| | Cardiac Volume | 1 | 1996 | 14 | 0.030 |
Why?
| | Diastole | 1 | 1996 | 146 | 0.030 |
Why?
| | Systole | 1 | 1996 | 181 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 337 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 174 | 0.030 |
Why?
| | Angiotensin I | 1 | 1995 | 7 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 6447 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 1997 | 241 | 0.030 |
Why?
| | Angiotensin II | 1 | 1995 | 101 | 0.030 |
Why?
| | Phenotype | 2 | 2002 | 3155 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2009 | 2588 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1426 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1999 | 779 | 0.030 |
Why?
| | Length of Stay | 1 | 2000 | 1349 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Interventional | 1 | 2014 | 30 | 0.030 |
Why?
| | Liposomes | 1 | 2016 | 262 | 0.030 |
Why?
| | Cattle | 1 | 2016 | 946 | 0.020 |
Why?
| | Punctures | 1 | 2013 | 41 | 0.020 |
Why?
| | Swine | 1 | 2016 | 825 | 0.020 |
Why?
| | Injections | 1 | 2014 | 199 | 0.020 |
Why?
| | Survival Rate | 1 | 1998 | 2090 | 0.020 |
Why?
| | Equipment Design | 1 | 2014 | 525 | 0.020 |
Why?
| | Metoprolol | 2 | 2002 | 26 | 0.020 |
Why?
| | Indium Radioisotopes | 1 | 1992 | 12 | 0.020 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 12 | 0.020 |
Why?
| | Ganglionic Blockers | 2 | 2002 | 9 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2013 | 193 | 0.020 |
Why?
| | Myocardial Infarction | 2 | 2006 | 1210 | 0.020 |
Why?
| | Chromogenic Compounds | 1 | 1991 | 4 | 0.020 |
Why?
| | Diacetyl | 1 | 1991 | 7 | 0.020 |
Why?
| | Time Factors | 2 | 2013 | 7123 | 0.020 |
Why?
| | Preoperative Care | 1 | 2013 | 380 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1991 | 112 | 0.020 |
Why?
| | Chick Embryo | 1 | 1991 | 132 | 0.020 |
Why?
| | Free Radicals | 1 | 1991 | 105 | 0.020 |
Why?
| | Aging | 1 | 2001 | 1969 | 0.020 |
Why?
| | Atrial Natriuretic Factor | 2 | 2002 | 55 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 2214 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 1991 | 247 | 0.020 |
Why?
| | Animals | 4 | 2016 | 38030 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2009 | 59 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 1111 | 0.020 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2009 | 66 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2002 | 2382 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 4316 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2002 | 2803 | 0.020 |
Why?
| | Heart Septal Defects | 1 | 2008 | 12 | 0.020 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2008 | 45 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 1991 | 500 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2440 | 0.020 |
Why?
| | Risk Factors | 2 | 2019 | 10885 | 0.020 |
Why?
| | Colorado | 2 | 2013 | 4554 | 0.020 |
Why?
| | Perfusion | 1 | 2009 | 251 | 0.020 |
Why?
| | Pulmonary Heart Disease | 1 | 2006 | 7 | 0.020 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2006 | 24 | 0.020 |
Why?
| | Epoprostenol | 1 | 2006 | 132 | 0.010 |
Why?
| | Pressure | 1 | 2006 | 226 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3413 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4560 | 0.010 |
Why?
| | Signal Transduction | 1 | 1999 | 5216 | 0.010 |
Why?
| | Models, Theoretical | 2 | 2000 | 558 | 0.010 |
Why?
| | Forecasting | 1 | 2006 | 390 | 0.010 |
Why?
| | Calcium | 1 | 1991 | 1190 | 0.010 |
Why?
| | Lung | 1 | 1997 | 4106 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 614 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 2005 | 107 | 0.010 |
Why?
| | Prostheses and Implants | 1 | 2005 | 137 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1991 | 4148 | 0.010 |
Why?
| | Sarcoplasmic Reticulum | 1 | 2002 | 40 | 0.010 |
Why?
| | Catecholamines | 1 | 2002 | 88 | 0.010 |
Why?
| | Evans Blue | 1 | 2002 | 8 | 0.010 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2002 | 19 | 0.010 |
Why?
| | Plasma Volume | 1 | 2002 | 20 | 0.010 |
Why?
| | Whole-Body Counting | 1 | 2002 | 7 | 0.010 |
Why?
| | Radioimmunotherapy | 1 | 2002 | 25 | 0.010 |
Why?
| | Ganglia, Autonomic | 1 | 2001 | 5 | 0.010 |
Why?
| | Ventricular Myosins | 1 | 2002 | 39 | 0.010 |
Why?
| | Trimethaphan | 1 | 2001 | 6 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 28 | 0.010 |
Why?
| | Phenylephrine | 1 | 2001 | 74 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1508 | 0.010 |
Why?
| | Men | 1 | 2001 | 21 | 0.010 |
Why?
| | Hormones | 1 | 2002 | 135 | 0.010 |
Why?
| | Cardiac Output | 1 | 2001 | 179 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2002 | 397 | 0.010 |
Why?
| | Diagnosis-Related Groups | 1 | 2000 | 35 | 0.010 |
Why?
| | Antibodies, Monoclonal | 2 | 2002 | 1505 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1454 | 0.010 |
Why?
| | Infant | 1 | 2014 | 10077 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 11853 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2002 | 519 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2007 | 1371 | 0.010 |
Why?
| | Xenon Radioisotopes | 1 | 1997 | 1 | 0.010 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 1 | 1997 | 6 | 0.010 |
Why?
| | Ventilation-Perfusion Ratio | 1 | 1997 | 11 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2378 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1997 | 335 | 0.010 |
Why?
| | Aerosols | 1 | 1997 | 145 | 0.010 |
Why?
| | Enalaprilat | 1 | 1995 | 1 | 0.010 |
Why?
| | Radiography | 1 | 1997 | 852 | 0.010 |
Why?
| | Iodine Radioisotopes | 1 | 1995 | 136 | 0.010 |
Why?
| | Disease Progression | 1 | 2002 | 2864 | 0.010 |
Why?
| | Child | 1 | 2014 | 22707 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1995 | 592 | 0.010 |
Why?
| | Kinetics | 1 | 1995 | 1567 | 0.010 |
Why?
| | Myosins | 1 | 1992 | 132 | 0.010 |
Why?
| | Dogs | 1 | 1992 | 458 | 0.010 |
Why?
| | United States | 1 | 2007 | 16098 | 0.000 |
Why?
| | Cardiovascular Diseases | 1 | 2001 | 2187 | 0.000 |
Why?
| | Mice | 1 | 1992 | 18329 | 0.000 |
Why?
|
|
Quaife's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|